Elite Pharmaceuticals Inc (ELTP) USD0.01

Sell:$0.45Buy:$0.45Price increased$0.07 (18.74%)

Prices delayed by at least 15 minutes
Sell:$0.45
Buy:$0.45
Change:Price increased$0.07 (18.74%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.45
Buy:$0.45
Change:Price increased$0.07 (18.74%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.

Key people

Nasrat Hakim
Chairman of the Board, President, Chief Executive Officer
Carter Julian Ward
Chief Financial Officer, Treasurer, Secretary
Douglas Plassche
Executive Vice President - Operations
Kirko Kirkov
Chief Commercial Officer
Davis S. Caskey
Independent Director
Barry H. Dash
Independent Director
Jeffrey A. Whitnell
Independent Director
Click to see more

Key facts

  • Shares in issue
    1.07bn
  • EPIC
    ELTP
  • ISIN
    US28659T2006
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $422.34m
  • Employees
    68
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.